Patents expiring in 2035

US 9056129

Precision-guided nanoparticle systems for drug delivery

Northwestern University · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056873

Substituted 6-aza-isoindolin-1-one derivatives

Takeda Pharmaceutical Company Limited · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056087

Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives

REGENERX BIOPHARMACEUTICALS, INC. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056102

VEGF-activated trail ligands

The Regents of the University of California · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9057104

Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype

VANDA PHARMACEUTICALS INC. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056046

Standardized extract and its use in the manufacture of a medicament

Botanic Century (Beijing) Co. Ltd. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9057069

Compositions and methods for inhibiting expression of Eg5 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056907

Human domain antibodies against components of the human insulin-like growth factor (IGF) system

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056100

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9055765

Dietary compositions and related methods of use

Northwestern University · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056891

Synthetic peptide inhibitors of Wnt pathway

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056924

Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571

The Regents of the University of California · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056847

Activity based probes (ABPs) interacting with glycosidases

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056154

High-yield activation of polymer surfaces for covalent attachment of molecules

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056127

Hydrogel composition based on co-polymer carrying multiple pendant sulphonic groups for use as a wound dressing

FIRST WATER LIMITED · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056130

Humanized Fc gamma R mice

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056054

Abuse resistant oral dosage forms

Elite Laboratories, Inc. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2882753

VERFAHREN ZUR HERSTELLUNG VON PEMETREXED UND EINEM LYSINSALZ DAVON

BERLIN CHEMIE AG [DE] · Granted Wed Jun 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jun 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061016

Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease

APREA AB · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062002

Substituted pyridine derivatives as FabI inhibitors

Aurigene Discovery Technologies Limited · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9060971

Combination pharmaceutical agents as inhibitors of HCV replication

Enanta Pharmaceuticals, Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062068

Protein kinase C inhibitors and uses thereof

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062347

Endothelin single nucleotide polymorphisms and methods of predicting β-adrenergic receptor targeting agent efficacy

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061063

Biodegradable lipids for the delivery of active agents

Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9060995

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9063153

Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9063125

Compositions comprising cells expressing cold- and menthol-sensitive receptor (CMR1) polypeptides

The Regents of the University of California · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062288

Therapeutic methods using adipose tissue-derived cell suspensions comprising adipocytes

Regeneus LTD · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062297

Yersinia pestis vaccine

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062093

Peptide compositions and methods for treating patients

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062095

Mutant double cyclized receptor peptides inhibiting β1-adrenoceptor antibodies

Julius-Maximilians-Universitat Wurzburg · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062075

Tetrahydropyridine derivatives as FabI inhibitors

Aurigene Discovery Technologies Limited · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062310

Compositions and methods for inhibiting expression of factor VII gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061048

Cyclic di-AMP induction of type I interferon

The Regents of the University of California · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062008

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062007

Cyclic amide BACE-1 inhibitors having a benzamide substituent

Pharmacopeia Drug Discovery, Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062052

Carboxamide compounds and methods for using the same

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061071

Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels

The Regents of the University of California · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061981

Diphenyl substituted cyclohexane derivatives, useful as modulators of the estrogen receptors beta

ACADIA Pharmaceuticals Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061055

Oncolytic adenovirus armed with therapeutic genes

The Board of Regents of the University of Texas System · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061030

sGC stimulators

IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061026

Oligomer-diarylpiperazine conjugates

Nektar Therapeutics · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061027

Enhanced delivery of drug compositions to treat life threatening infections

The Board of Regents of the University of Texas System · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9060941

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Takeda Pharmaceutical Company Limited · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2886116

Benzodioxol-Derivate zur Verwendung in der Behandlung von Aufmerksamkeitsdefizitstörung und/oder Hyperaktivität

BIOCODEX [FR] · Granted Wed Jun 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jun 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2934118

PROPIONATE DE CORTEXOLONE-17' DESTINE A ETRE UTILISE DANS LE TRAITEMENT DE LESIONS CUTANEES ET/OU DE TROUBLES DE LA PEAU ATROPHIQUE

CASSIOPEA S P A [IT] · Granted Thu Jun 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9068002

Treatment of multiple sclerosis and/or rheumatoid arthritis

Universität Regensburg · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9067968

Tight junction protein modulators and uses thereof

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)